2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

This study is ongoing, but not recruiting participants.

Study NCT00483067 Information provided by M.D. Anderson Cancer Center

First Received: June 5, 2007 Last Updated: June 6, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)